AMPH
Price
$29.42
Change
+$0.23 (+0.79%)
Updated
Sep 5 closing price
Capitalization
1.37B
65 days until earnings call
VTRS
Price
$10.51
Change
+$0.18 (+1.74%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
12.24B
65 days until earnings call
Interact to see
Advertisement

AMPH vs VTRS

Header iconAMPH vs VTRS Comparison
Open Charts AMPH vs VTRSBanner chart's image
Amphastar Pharmaceuticals
Price$29.42
Change+$0.23 (+0.79%)
Volume$414.94K
Capitalization1.37B
Viatris
Price$10.51
Change+$0.18 (+1.74%)
Volume$168.79K
Capitalization12.24B
AMPH vs VTRS Comparison Chart in %
Loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMPH vs. VTRS commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a Buy and VTRS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (AMPH: $29.42 vs. VTRS: $10.50)
Brand notoriety: AMPH and VTRS are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMPH: 77% vs. VTRS: 88%
Market capitalization -- AMPH: $1.37B vs. VTRS: $12.24B
AMPH [@Pharmaceuticals: Generic] is valued at $1.37B. VTRS’s [@Pharmaceuticals: Generic] market capitalization is $12.24B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 0 FA rating(s) are green whileVTRS’s FA Score has 2 green FA rating(s).

  • AMPH’s FA Score: 0 green, 5 red.
  • VTRS’s FA Score: 2 green, 3 red.
According to our system of comparison, VTRS is a better buy in the long-term than AMPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 5 TA indicator(s) are bullish while VTRS’s TA Score has 4 bullish TA indicator(s).

  • AMPH’s TA Score: 5 bullish, 5 bearish.
  • VTRS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AMPH is a better buy in the short-term than VTRS.

Price Growth

AMPH (@Pharmaceuticals: Generic) experienced а -3.92% price change this week, while VTRS (@Pharmaceuticals: Generic) price change was -0.47% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Reported Earning Dates

AMPH is expected to report earnings on Nov 10, 2025.

VTRS is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTRS($12.2B) has a higher market cap than AMPH($1.37B). VTRS has higher P/E ratio than AMPH: VTRS (236.20) vs AMPH (11.02). VTRS YTD gains are higher at: -13.813 vs. AMPH (-20.765). VTRS has more cash in the bank: 406M vs. AMPH (232M). AMPH has less debt than VTRS: AMPH (655M) vs VTRS (14.5B).
AMPHVTRSAMPH / VTRS
Capitalization1.37B12.2B11%
EBITDA248MN/A-
Gain YTD-20.765-13.813150%
P/E Ratio11.02236.205%
Revenue723MN/A-
Total Cash232M406M57%
Total Debt655M14.5B5%
FUNDAMENTALS RATINGS
AMPH vs VTRS: Fundamental Ratings
AMPH
VTRS
OUTLOOK RATING
1..100
2085
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
11
Undervalued
PROFIT vs RISK RATING
1..100
82100
SMR RATING
1..100
4896
PRICE GROWTH RATING
1..100
4543
P/E GROWTH RATING
1..100
801
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTRS's Valuation (11) in the null industry is somewhat better than the same rating for AMPH (67) in the Pharmaceuticals Other industry. This means that VTRS’s stock grew somewhat faster than AMPH’s over the last 12 months.

AMPH's Profit vs Risk Rating (82) in the Pharmaceuticals Other industry is in the same range as VTRS (100) in the null industry. This means that AMPH’s stock grew similarly to VTRS’s over the last 12 months.

AMPH's SMR Rating (48) in the Pharmaceuticals Other industry is somewhat better than the same rating for VTRS (96) in the null industry. This means that AMPH’s stock grew somewhat faster than VTRS’s over the last 12 months.

VTRS's Price Growth Rating (43) in the null industry is in the same range as AMPH (45) in the Pharmaceuticals Other industry. This means that VTRS’s stock grew similarly to AMPH’s over the last 12 months.

VTRS's P/E Growth Rating (1) in the null industry is significantly better than the same rating for AMPH (80) in the Pharmaceuticals Other industry. This means that VTRS’s stock grew significantly faster than AMPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHVTRS
RSI
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
63%
Bearish Trend 2 days ago
68%
Momentum
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 2 days ago
59%
MACD
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
68%
Declines
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
66%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
62%
Bullish Trend 2 days ago
51%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 2 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HRIDX14.740.09
+0.61%
Harbor Diversified Intl All Cp Admin
STPAX23.100.10
+0.43%
Saratoga Technology & Comm A
FDEKX75.74N/A
N/A
Fidelity Disciplined Equity K
TTMIX177.00N/A
N/A
T. Rowe Price Comm & Tech I
MIEFX15.32N/A
N/A
Matthews Emerging Markets Equity Ins

AMPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMPH has been loosely correlated with AMRX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if AMPH jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
+0.79%
AMRX - AMPH
34%
Loosely correlated
+0.73%
ZTS - AMPH
32%
Poorly correlated
+0.08%
HROW - AMPH
29%
Poorly correlated
+2.18%
VTRS - AMPH
28%
Poorly correlated
+1.65%
ANIP - AMPH
28%
Poorly correlated
-0.68%
More

VTRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with ELAN. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then ELAN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
-2.09%
ELAN - VTRS
53%
Loosely correlated
+0.69%
ZTS - VTRS
46%
Loosely correlated
+0.51%
AMRX - VTRS
44%
Loosely correlated
+0.10%
EBS - VTRS
43%
Loosely correlated
-2.55%
COLL - VTRS
37%
Loosely correlated
-0.91%
More